COVID plasma treatment
As COVID hospitalizations rise, a new study finds that antibody-rich blood is an early treatment option. Dr. David Sullivan, the co-lead author of the study, joins FOX 5 to talk more about what this means.
As COVID hospitalizations rise, a new study finds that antibody-rich blood is an early treatment option. Dr. David Sullivan, the co-lead author of the study, joins FOX 5 to talk more about what this means.